HCW Biologics is trading 5.01% down now at $3.41, with apparent profit-taking adding pressure after a sharp multi-session rally.
- Shares rose from $2.18 on August 21 to $3.59 on August 31, including gains of 17.41% on August 27 and 8.20% on August 28.
- No new company-specific announcement dated August 31 or September 1 was identified.
- Broader biotech weakness and risk-off markets are also weighing on the stock.